Advertisement
Research Article Free access | 10.1172/JCI106981
Department of Pharmacology, University of Colorado School of Medicine, Denver, Colorado 80220
Department of Psychiatry, New York University Medical Center, New York 10016
Find articles by Waymire, J. in: JCI | PubMed | Google Scholar
Department of Pharmacology, University of Colorado School of Medicine, Denver, Colorado 80220
Department of Psychiatry, New York University Medical Center, New York 10016
Find articles by Weiner, N. in: JCI | PubMed | Google Scholar
Department of Pharmacology, University of Colorado School of Medicine, Denver, Colorado 80220
Department of Psychiatry, New York University Medical Center, New York 10016
Find articles by Schneider, F. in: JCI | PubMed | Google Scholar
Department of Pharmacology, University of Colorado School of Medicine, Denver, Colorado 80220
Department of Psychiatry, New York University Medical Center, New York 10016
Find articles by Goldstein, M. in: JCI | PubMed | Google Scholar
Department of Pharmacology, University of Colorado School of Medicine, Denver, Colorado 80220
Department of Psychiatry, New York University Medical Center, New York 10016
Find articles by Freedman, L. in: JCI | PubMed | Google Scholar
Published July 1, 1972 - More info
The properties of partially purified tyrosine hydroxylase from six pheochromocytomas were compared with partially purified normal human and bovine adrenal medulla enzyme. Substrate and inhibition kinetics, cofactor requirements, and intracellular localization of the enzyme from normal and tumor chromaffin tissue of humans were similar, as was the amount of enzyme activity per gram of tissue. Contrary to previous reports, the sensitivity to catecholamine inhibition of the pheochromocytoma enzyme from the six tumors studied was similar to that of both human and bovine adrenal medulla tyrosine hydroxylase. These results suggest that the excessive synthesis and secretion of catecholamines in some pheochromocytomas is not the result of a reduced sensitivity of tyrosine hydroxylase to catecholamine inhibition.